Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Oct 15;98(8):1826–1834. doi: 10.1172/JCI118983

Insulin and insulin-like growth factor I differentially induce alpha1-adrenergic receptor subtype expression in rat vascular smooth muscle cells.

Z W Hu 1, X Y Shi 1, B B Hoffman 1
PMCID: PMC507622  PMID: 8878434

Abstract

Hyperinsulinemia has been implicated as an important risk factor for the development of accelerated cardiovascular disease. We wondered if insulin or IGF-I induced expression of alpha1 adrenergic receptors in vascular smooth muscle cells (VSMCs) which could enhance smooth muscle contraction and cell growth activated by catecholamines. Rat aortic VSMCs were incubated with insulin or IGF-I for various times and expression of alpha1 receptors was detected using [3H]prazosin binding. Both insulin and IGF-I increased alpha1 receptor number; also, these peptides increased expression of the alpha1D receptor gene with no change in expression of the alpha1B receptor gene as detected by RNase protection assays. Using Western blotting, we found that these peptides increased expression of the alpha1D receptor subtype in these cells. Increased expression of the alpha1D receptor mRNA was inhibited by the receptor tyrosine kinase inhibitor genistein and the PI 3-kinase inhibitor wortmannin but was not inhibited by protein kinase C inhibitor H7 or the L-type calcium channel blocker nifedipine. Preincubation of cells with insulin or IGF-I enhanced subsequent norepinephrine stimulation of mitogen activated kinase activity. These results suggest that insulin/IGF-I regulate expression of alpha1 receptors in VSMCs and potentially enhance the effects of catecholamines in settings of hyperinsulinemia.

Full Text

The Full Text of this article is available as a PDF (463.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnqvist H. J., Bornfeldt K. E., Chen Y., Lindström T. The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metabolism. 1995 Oct;44(10 Suppl 4):58–66. doi: 10.1016/0026-0495(95)90222-8. [DOI] [PubMed] [Google Scholar]
  2. Banskota N. K., Taub R., Zellner K., Olsen P., King G. L. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes. 1989 Jan;38(1):123–129. doi: 10.2337/diab.38.1.123. [DOI] [PubMed] [Google Scholar]
  3. Bell L., Madri J. A. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ Res. 1989 Oct;65(4):1057–1065. doi: 10.1161/01.res.65.4.1057. [DOI] [PubMed] [Google Scholar]
  4. Blaes N., Boissel J. P. Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J Cell Physiol. 1983 Aug;116(2):167–172. doi: 10.1002/jcp.1041160207. [DOI] [PubMed] [Google Scholar]
  5. Bornfeldt K. E., Gidlöf R. A., Wasteson A., Lake M., Skottner A., Arnqvist H. J. Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia. 1991 May;34(5):307–313. doi: 10.1007/BF00405001. [DOI] [PubMed] [Google Scholar]
  6. Bylund D. B., Regan J. W., Faber J. E., Hieble J. P., Triggle C. R., Ruffolo R. R., Jr Vascular alpha-adrenoceptors: from the gene to the human. Can J Physiol Pharmacol. 1995 May;73(5):533–543. doi: 10.1139/y95-068. [DOI] [PubMed] [Google Scholar]
  7. Devedjian J. C., Fargues M., Denis-Pouxviel C., Daviaud D., Prats H., Paris H. Regulation of the alpha 2A-adrenergic receptor in the HT29 cell line. Effects of insulin and growth factors. J Biol Chem. 1991 Aug 5;266(22):14359–14366. [PubMed] [Google Scholar]
  8. Exton J. H. Some thoughts on the mechanism of action of insulin. Diabetes. 1991 May;40(5):521–526. doi: 10.2337/diab.40.5.521. [DOI] [PubMed] [Google Scholar]
  9. Ferrannini E. Physiological and metabolic consequences of obesity. Metabolism. 1995 Sep;44(9 Suppl 3):15–17. doi: 10.1016/0026-0495(95)90313-5. [DOI] [PubMed] [Google Scholar]
  10. Frank H. J., Levin E. R., Hu R. M., Pedram A. Insulin stimulates endothelin binding and action on cultured vascular smooth muscle cells. Endocrinology. 1993 Sep;133(3):1092–1097. doi: 10.1210/endo.133.3.8365355. [DOI] [PubMed] [Google Scholar]
  11. Gao B., Kunos G. Transcription of the rat alpha 1B adrenergic receptor gene in liver is controlled by three promoters. J Biol Chem. 1994 Jun 3;269(22):15762–15767. [PubMed] [Google Scholar]
  12. Gao B., Spector M. S., Kunos G. The rat alpha 1B adrenergic receptor gene middle promoter contains multiple binding sites for sequence-specific proteins including a novel ubiquitous transcription factor. J Biol Chem. 1995 Mar 10;270(10):5614–5619. doi: 10.1074/jbc.270.10.5614. [DOI] [PubMed] [Google Scholar]
  13. Greenberg S. M., Koo E. H., Selkoe D. J., Qiu W. Q., Kosik K. S. Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7104–7108. doi: 10.1073/pnas.91.15.7104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hadcock J. R., Port J. D., Gelman M. S., Malbon C. C. Cross-talk between tyrosine kinase and G-protein-linked receptors. Phosphorylation of beta 2-adrenergic receptors in response to insulin. J Biol Chem. 1992 Dec 25;267(36):26017–26022. [PubMed] [Google Scholar]
  15. Hall J. E., Brands M. W., Zappe D. H., Alonso Galicia M. Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences, or merely correlations? Proc Soc Exp Biol Med. 1995 Apr;208(4):317–329. doi: 10.3181/00379727-208-43862b. [DOI] [PubMed] [Google Scholar]
  16. Hieble J. P., Bylund D. B., Clarke D. E., Eikenburg D. C., Langer S. Z., Lefkowitz R. J., Minneman K. P., Ruffolo R. R., Jr International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev. 1995 Jun;47(2):267–270. [PubMed] [Google Scholar]
  17. Hsueh W. A., Buchanan T. A. Obesity and hypertension. Endocrinol Metab Clin North Am. 1994 Jun;23(2):405–427. [PubMed] [Google Scholar]
  18. Hu Z. W., Shi X. Y., Lin R. Z., Hoffman B. B. Alpha1 adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells. Role in mitogenesis. J Biol Chem. 1996 Apr 12;271(15):8977–8982. doi: 10.1074/jbc.271.15.8977. [DOI] [PubMed] [Google Scholar]
  19. Hu Z. W., Shi X. Y., Okazaki M., Hoffman B. B. Angiotensin II induces transcription and expression of alpha 1-adrenergic receptors in vascular smooth muscle cells. Am J Physiol. 1995 Mar;268(3 Pt 2):H1006–H1014. doi: 10.1152/ajpheart.1995.268.3.H1006. [DOI] [PubMed] [Google Scholar]
  20. Jhun B. H., Rose D. W., Seely B. L., Rameh L., Cantley L., Saltiel A. R., Olefsky J. M. Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression. Mol Cell Biol. 1994 Nov;14(11):7466–7475. doi: 10.1128/mcb.14.11.7466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Karns L. R., Kariya K., Simpson P. C. M-CAT, CArG, and Sp1 elements are required for alpha 1-adrenergic induction of the skeletal alpha-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. J Biol Chem. 1995 Jan 6;270(1):410–417. doi: 10.1074/jbc.270.1.410. [DOI] [PubMed] [Google Scholar]
  22. Ko Y., Sachinidis A., Wieczorek A. J., Appenheimer M., Düsing R., Vetter H. Insulin enhances angiotensin II induced DNA synthesis in vascular smooth muscle cells of the rat. Clin Investig. 1993 May;71(5):379–382. doi: 10.1007/BF00186627. [DOI] [PubMed] [Google Scholar]
  23. Landsberg L. Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system. J Cardiovasc Pharmacol. 1994;23 (Suppl 1):S1–S8. [PubMed] [Google Scholar]
  24. Laws A., Reaven G. M. Insulin resistance and risk factors for coronary heart disease. Baillieres Clin Endocrinol Metab. 1993 Oct;7(4):1063–1078. doi: 10.1016/s0950-351x(05)80245-9. [DOI] [PubMed] [Google Scholar]
  25. Lee P. D., Hintz R. L., Rosenfeld R. G., Benitz W. E. Presence of insulinlike growth factor receptors and lack of insulin receptors on fetal bovine smooth muscle cells. In Vitro Cell Dev Biol. 1988 Sep;24(9):921–926. doi: 10.1007/BF02623903. [DOI] [PubMed] [Google Scholar]
  26. Majesky M. W., Daemen M. J., Schwartz S. M. Alpha 1-adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. J Biol Chem. 1990 Jan 15;265(2):1082–1088. [PubMed] [Google Scholar]
  27. Meehan W. P., Darwin C. H., Maalouf N. B., Buchanan T. A., Saad M. F. Insulin and hypertension: are they related? Steroids. 1993 Dec;58(12):621–634. doi: 10.1016/0039-128x(93)90105-v. [DOI] [PubMed] [Google Scholar]
  28. Milano C. A., Dolber P. C., Rockman H. A., Bond R. A., Venable M. E., Allen L. F., Lefkowitz R. J. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):10109–10113. doi: 10.1073/pnas.91.21.10109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Nakaki T., Nakayama M., Yamamoto S., Kato R. Alpha 1-adrenergic stimulation and beta 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol Pharmacol. 1990 Jan;37(1):30–36. [PubMed] [Google Scholar]
  30. Okazaki M., Hu Z. W., Fujinaga M., Hoffman B. B. Alpha 1 adrenergic receptor-induced c-fos gene expression in rat aorta and cultured vascular smooth muscle cells. J Clin Invest. 1994 Jul;94(1):210–218. doi: 10.1172/JCI117309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Perondi R., Saino A., Tio R. A., Pomidossi G., Gregorini L., Alessio P., Morganti A., Zanchetti A., Mancia G. ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease. Circulation. 1992 Jun;85(6):2004–2013. doi: 10.1161/01.cir.85.6.2004. [DOI] [PubMed] [Google Scholar]
  32. Ramarao C. S., Denker J. M., Perez D. M., Gaivin R. J., Riek R. P., Graham R. M. Genomic organization and expression of the human alpha 1B-adrenergic receptor. J Biol Chem. 1992 Oct 25;267(30):21936–21945. [PubMed] [Google Scholar]
  33. Reaven G. M., Hoffman B. B. A role for insulin in the aetiology and course of hypertension? Lancet. 1987 Aug 22;2(8556):435–437. doi: 10.1016/s0140-6736(87)90968-8. [DOI] [PubMed] [Google Scholar]
  34. Reaven G. M. Pathophysiology of insulin resistance in human disease. Physiol Rev. 1995 Jul;75(3):473–486. doi: 10.1152/physrev.1995.75.3.473. [DOI] [PubMed] [Google Scholar]
  35. Standley P. R., Bakir M. H., Sowers J. R. Vascular insulin abnormalities, hypertension, and accelerated atherosclerosis. Am J Kidney Dis. 1993 Jun;21(6 Suppl 3):39–46. doi: 10.1016/0272-6386(93)70123-g. [DOI] [PubMed] [Google Scholar]
  36. Standley P. R., Rose K. A. Insulin and insulin-like growth factor-1 modulation of glucose transport in arterial smooth muscle cells: implication of GLUT-4 in the vasculature. Am J Hypertens. 1994 Apr;7(4 Pt 1):357–362. doi: 10.1093/ajh/7.4.357. [DOI] [PubMed] [Google Scholar]
  37. Thorburn J., Frost J. A., Thorburn A. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J Cell Biol. 1994 Sep;126(6):1565–1572. doi: 10.1083/jcb.126.6.1565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Thorburn J., Thorburn A. The tyrosine kinase inhibitor, genistein, prevents alpha-adrenergic-induced cardiac muscle cell hypertrophy by inhibiting activation of the Ras-MAP kinase signaling pathway. Biochem Biophys Res Commun. 1994 Aug 15;202(3):1586–1591. doi: 10.1006/bbrc.1994.2113. [DOI] [PubMed] [Google Scholar]
  39. Townsend R. R., Yamamoto R., Nickols M., DiPette D. J., Nickols G. A. Insulin enhances pressor responses to norepinephrine in rat mesenteric vasculature. Hypertension. 1992 Feb;19(2 Suppl):II105–II110. doi: 10.1161/01.hyp.19.2_suppl.ii105. [DOI] [PubMed] [Google Scholar]
  40. Vargas H. M., Gorman A. J. Vascular alpha-1 adrenergic receptor subtypes in the regulation of arterial pressure. Life Sci. 1995;57(25):2291–2308. doi: 10.1016/0024-3205(95)02224-7. [DOI] [PubMed] [Google Scholar]
  41. Weidmann P., Böhlen L., de Courten M. Insulin resistance and hyperinsulinemia in hypertension. J Hypertens Suppl. 1995 Aug;13(2):S65–S72. doi: 10.1097/00004872-199508001-00010. [DOI] [PubMed] [Google Scholar]
  42. Zemel M. B., Kim J. H., Woychik R. P., Michaud E. J., Kadwell S. H., Patel I. R., Wilkison W. O. Agouti regulation of intracellular calcium: role in the insulin resistance of viable yellow mice. Proc Natl Acad Sci U S A. 1995 May 23;92(11):4733–4737. doi: 10.1073/pnas.92.11.4733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. van Kleef E. M., Smits J. F., De Mey J. G., Cleutjens J. P., Lombardi D. M., Schwartz S. M., Daemen M. J. Alpha 1-adrenoreceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ Res. 1992 Jun;70(6):1122–1127. doi: 10.1161/01.res.70.6.1122. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES